Mireille Sanders
Geschäftsführer bei PHARMING GROUP N.V.
Vermögen: 748 842 $ am 30.04.2024
Aktive Positionen von Mireille Sanders
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| PHARMING GROUP N.V. | Geschäftsführer | 15.12.2020 | - |
| Corporate Officer/Principal | 01.05.2019 | 15.12.2020 |
Karriereverlauf von Mireille Sanders
Ehemalige bekannte Positionen von Mireille Sanders
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Janssen Pharmaceuticals, Inc.
 Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Corporate Officer/Principal | 01.01.2016 | 01.01.2019 |
Ausbildung von Mireille Sanders
| Technische Universiteit Eindhoven | Graduate Degree |
Statistik
International
| Niederlande | 3 |
| Vereinigte Staaten | 2 |
Operativ
| Corporate Officer/Principal | 2 |
| Chief Operating Officer | 1 |
| Graduate Degree | 1 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| PHARMING GROUP N.V. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Janssen Pharmaceuticals, Inc.
Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Health Technology |
- Börse
- Insiders
- Mireille Sanders
- Erfahrung
